Connection

Michael Horner to Schizophrenia

This is a "connection" page, showing publications Michael Horner has written about Schizophrenia.
Connection Strength

0.227
  1. Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res. 2008 Apr; 101(1-3):142-51.
    View in: PubMed
    Score: 0.064
  2. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res. 2007 Jul; 93(1-3):131-5.
    View in: PubMed
    Score: 0.061
  3. Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol. 2006 Oct; 9(5):603-5.
    View in: PubMed
    Score: 0.055
  4. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.